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Summary
Background Many studies report that damp housing conditions are associated with respi-
ratory symptoms. Less is known about mechanisms and possible effect modifiers. Studies
of dampness in relation to allergic sensitization and eczema are scarce.
Objective We study the influence of damp housing conditions world-wide on symptoms
and objective outcomes.
Methods Cross-sectional studies of 8–12-year-old children in 20 countries used standard-
ized methodology from Phase Two of the International Study of Asthma and Allergies in
Childhood (ISAAC). Symptoms of asthma, rhinitis and eczema, plus residential exposure
to dampness and moulds, were ascertained by parental questionnaires (n = 46 051). Skin
examination, skin prick tests (n = 26 967) and hypertonic saline bronchial challenge
(n = 5713) were performed. In subsamples stratified by wheeze (n = 1175), dust was sam-
pled and analysed for house dust mite (HDM) allergens and endotoxin.
Results Current exposure to dampness was more common for wheezy children (pooled
odds ratio 1.58, 95% CI 1.40–1.79) and was associated with greater symptom severity
among wheezers, irrespective of atopy. A significant (P < 0.01) adverse effect of dampness
was also seen for cough and phlegm, rhinitis and reported eczema, but not for examined
eczema, nor bronchial hyperresponsiveness. HDM sensitization was more common in
damp homes (OR 1.16, 1.03–1.32). HDM-allergen levels were higher in damp homes and
were positively associated with HDM-sensitization, but not wheeze.
Conclusion A consistent association of dampness with respiratory and other symptoms
was found in both affluent and non-affluent countries, among both atopic and non-atopic
children. HDM exposure and sensitization may contribute, but the link seems to be related
principally to non-atopic mechanisms.
Keywords asthma, atopy, dampness, house dust mite, ISAAC, moulds, respiratory and
allergic symptoms, wheeze
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Introduction
Dampness and mould growth in the home have been
shown to be associated with wheeze and asthma in
many geographical settings [1]. Results from non-afflu-
ent countries are scarce and results are inconsistent.
Positive associations have been found in Nigeria [2]
and Kenya [3], but there was no association in a South
African study [4]. The most recent comprehensive
review [1] rated the evidence as ‘sufficient for associa-
tion and strongly suggestive of causality’ only for
asthma exacerbation, and as ‘sufficient for association’
for numerous other outcomes, including wheeze, cough
and allergic rhinitis.
*The Phase Two Study Group is listed in Appendix.
The principal mechanisms by which damp housing
could cause or exacerbate asthma have usually been
considered to relate to indoor moulds and house dust
mites. Many species of indoor moulds, including their
fragments and spores, possess allergenic proteins (e.g.
[5–7]), and a positive association of sensitization to
moulds with both building dampness and current
asthma was reported from Sweden [8]. A Dutch study
found that the observed effect of dampness on respira-
tory symptoms was mainly mediated by sensitization to
house dust mites (HDM), noting that sensitization to
HDM was much more common than sensitization to
moulds [9]. A study from Germany found an increase
in BHR persistence with increasing HDM-allergen levels
and a significant correlation between HDM allergens
and dampness [10].
Alternatively, non-allergic mechanisms related to
dampness and/or moulds include inflammatory reactions
to volatile organic compounds [11, 12] or to cell wall
components such as 1,3-b-D-glucan [13–15]. Few studies
have specifically compared the effects of dampness
between atopic and non-atopic individuals, but reviews
have concluded that the association of dampness with
respiratory symptoms can be observed in non-atopic as
well as atopic individuals [1, 16]. Even fewer studies have
looked at potential other effect modifiers.
In this article, we report on the association with
damp housing conditions and/or visible moulds in an
international study investigating the symptom preva-
lence of asthma, rhinitis and eczema based on the
results from 28 centres world-wide differentiating also
between atopic and non-atopic individuals. In addition,
the sample size in this international study is large
enough to investigate in detail potential effect modifi-
cation by family history of allergic disease symptoms
and living conditions such as parental smoking, pres-
ence of carpets, type of bedding. Dust samples collected
in a subsample allowed us to specifically investigate
whether house dust mite allergen levels were higher in
damp homes, and whether HDM levels were related to a
higher occurrence of wheeze.
Methods
Study populations and field work
The methods of ISAAC Phase Two have been described
in detail elsewhere [17, 18]. Briefly, random samples of
at least 10 schools from defined geographical areas
were chosen and children (n > 1,000 per centre) attend-
ing classes with a majority of 9–11 year olds were
invited to participate. Standardized parental question-
naires were used. In two countries (Brazil and India),
the questions were posed by trained interviewers
because illiteracy was common.
The ISAAC Phase Two methodology allowed objective
measurements to be performed either in the full sample
(option A) or in stratified random subsamples of chil-
dren (option B) [17]. Most centres invited all children to
participate in the skin prick testing, while bronchial hy-
perresponsiveness tests and house dust sampling were
carried out mostly in stratified random subsamples of
children with and without reports of wheeze in the past
year (targeting 100 per centre in each stratum).
All centres obtained approval by local ethics commit-
tees and investigators were trained in one location to
assure comparable data quality [17]. Fuller details of
the skin examination, bronchial responsiveness and skin
prick tests to six aeroallergens (Dermatophagoides pter-
onyssinus, D. farinae, cat dander, Alternaria tenuis,
mixed tree pollen and mixed grass pollen) have been
published elsewhere [19–21] and can be found at
http://isaac.auckland.ac.nz/phases/phasetwo/phasetwo.
html and in [22].
Questionnaire data
Standardized parental questionnaires including detailed
questions on the occurrence and severity of symptoms of
asthma (wheeze), rhinitis (with and without conjunctivi-
tis) and flexural eczema were administered. These were
identical to those used in ISAAC Phase One for parents of
children aged 6–7 years [17, 23]. In addition, in many
(but not all) centres, questions about cough and phlegm
were asked (http://isaac.auckland.ac.nz/phases/phase-
two/phasetwo.html, and Online Repository).
Exposure to dampness and moulds was assessed by
the following questions: ‘Does or did the child’s home
have damp spots on the walls or ceiling? At present?
During the child’s first year of life?’ and ‘Does or did
the child’s home have visible moulds or fungus on the
walls or ceiling? At present? During the child’s first
year of life?’ For most analyses presented here, the child
was considered ‘exposed’ if damp spots and/or moulds
were reported. In a few centres, there were minor devia-
tions in the exact wording, see the Online Repository.
Dust sampling and laboratory analysis
Mattress dust samples were collected in eight centres in
six countries and analysed for house dust mite allergen.
These centres are as follows: Tirana (Albania), Dresden
and Munich (Germany), Rome (Italy), Hawke’s Bay
(New Zealand), Link€oping and €Ostersund (Sweden), and
West Sussex (UK). In addition, in all but the German
centres, living room floor dust samples were collected
and analysed for endotoxin. In all centres, one child
per household was included. As a result of insufficient
numbers of children with a history of wheeze in some
centres and as a result of non-response, in most centres
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the aim of including 100 wheezers was not achieved.
The actual number of participants for which house dust
samples were analysed varied from 49 (Rome) to 231
(Hawke’s Bay).
Dust samples were collected on filters according to a
standardized protocol as described earlier [24, 25]. Lab-
oratory analysis of dust samples from European centres
took place at the Institute for Risk Assessment Sciences
(Utrecht University, Utrecht, the Netherlands). Dust sam-
ples from New Zealand were analysed at the laboratory
of the Wellington Asthma Research Group (Wellington
School of Medicine and Health Sciences, Wellington,
New Zealand).
After weighing, the whole dust sample including fil-
ter was extracted using Tween-20 and water and then
analysed for house dust mite allergens Dermatophago-
ides pteronyssinus (Der p 1) and Dermatophagoides fari-
nae (Der f 1) with enzyme immunoassays as described
earlier [17]. Endotoxin concentrations were determined
with a kinetic chromogenic Limulus amoebocyte lysate
(LAL) test as described previously [26, 27].
Allergen and endotoxin levels were expressed per
gram of dust. Samples with non-detectable amounts of
house dust mite allergen or endotoxin were assigned a
value of two thirds of the lowest overall observed
detectable value.
Statistical analysis
Prevalences and odds ratios (ORs) for health outcomes
were calculated with the SURVEY-procedures of SAS
(V9.2) using, where necessary, the appropriate weight-
ing and variance estimation to account for stratified
subsampling [28, 29]. The association of allergen and
endotoxin levels with the mould exposure was esti-
mated with linear regression based on log-transformed
data (base10) and results are presented as the ratio of
the geometric mean concentration in exposed children
to that in non-exposed children. When modelling
dichotomous outcomes in relation to exposure, separate
logistic regression models were fitted for each centre
using PROC SURVEYLOGISTIC and combined estimates
of the odds ratio were derived using random effects
meta-analysis [30]. For the analyses involving allergen
and endotoxin levels, data for all respective centres
were pooled, because of the lower number of children
and centres for these analyses, which would make a
random effects meta-analysis less reliable. To take
account of the centre, adjustment terms for the individ-
ual centres were added.
Potential confounders were tested by including them
one by one in the models fitted by centre and only
those that resulted in a notable (10% or greater) change
of the combined estimate were retained (Table S2 in the
Online Repository). The potential confounders included
sex, reported parental allergic disease, pets, use of any
combustion fuels for heating or cooking, maternal
smoking in pregnancy, anybody smoking in the child’s
home, older siblings, maternal education and bedroom
sharing. Based on the change-in-parameter criterion,
only parental allergic disease was retained in the fully
adjusted model.
The influence of potential effect modifiers was inves-
tigated by performing stratified centre-specific analy-
ses, calculating the combined effect for each stratum
and evaluating the difference between strata-specific
estimates. Due to small cell counts in some centres in
specific strata, the number of centres contributing to
the stratum-specific estimates may differ from the
number of centres in the corresponding unstratified
analyses.
Centres classified by the World Bank as ‘high income
countries’ (i.e. GNI per capita per year in 2001  9200
US $) were combined in a group called ‘affluent coun-
tries’ and the remaining centres in a group called ‘non-
affluent countries’ [31, 32].
Results
Table 1 presents, for each study centre, the prevalence
of the principal exposure variable (current dampness
and/or mould in the child’s home) and the potential
effect modifiers. An expanded version including health-
related outcomes is included in the Online Repository
(Table S1). The prevalence of homes with reported cur-
rent damp spots and/or moulds varied widely, from
1.5% in €Ostersund to 48% in Tallinn. About half of the
children who were currently exposed were reported also
to have been exposed during the first year of life, but
again, this proportion varied greatly between centres.
In the centres that had collected dust samples, the
concentration of house dust mite allergens in sampled
dust was lowest in Sweden (geometric mean of 46.1
and 61.5 ng/g) and highest in New Zealand
(22582.5 ng/g). Endotoxin levels in sampled dust were
more similar among centres with a minimum again in
Sweden (geometric mean of 7032.6 endotoxin units
(EU)/g in Link€oping) and highest in Albania
(32673.2 EU/g).
Association of dampness with wheeze prevalence and
severity
The associations calculated for wheeze in the past year
were similar in magnitude for current exposures to
dampness alone, moulds alone, and both, and also for
exposures in the first year and at present (Fig. 1).
Therefore, to maximize the power of the analyses, we
analysed the combination damp spots and/or moulds as
the principal exposure, allowing the maximum number
© 2013 John Wiley & Sons Ltd, Clinical & Experimental Allergy, 43 : 762–774
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of children to be retained in the analysis. In this article,
unless otherwise stated, we show results for current
exposure, based on data for 46 051 children from 28
centres.
The combined odds ratio for wheeze in the past year in
relation to dampness was 1.58 (95%-CI:1.40;1.79) and
there was a significantly (P < 0.01) stronger association
in non-affluent centres (Table 2). Association results for
each centre individually are shown in a forest plot in the
Online Repository (Fig. S1). There was no indication of
effect modification by reported parental allergic disease,
nor by skin prick test sensitization to any allergen, nor
by sensitization to HDM. None of the indoor living con-
ditions investigated seemed to influence markedly the
observed association between current dampness and
recent wheeze. This association was also robust to adjust-
ment for potential confounding factors (Table 2).
Among wheezers, exposure to dampness increased
the occurrence of severe wheeze with odds ratios of
1.16 (0.96;1.41) for having four or more wheezing
attacks per week, 1.33 (1.08;1.63) for speech limiting
wheeze and 1.60 (1.13;2.25) for wheeze disturbing
sleep. This held true for children that were exposed
only at present [ORs of 1.17 (0.86;1.60), 2.21 (1.28;3.80)
and 1.46 (1.03;2.07)], as well as for those only exposed
in the first year of life [ORs of 1.36 (1.05;1.76), 1.49
(1.01;2.19) and 1.51 (1.12;2.04)].
Dust concentrations of mite allergen and endotoxin
Analysis of the house dust mite allergen and endotoxin
levels for eight centres showed that the concentrations
of house dust mite allergen in mattresses were higher in
damp homes, whereas endotoxin concentrations in floor
dust were not (Fig. 2). However, in this subsample,
log10-transformed HDM-allergen levels were not related
to wheeze in the past year [OR 0.91 (0.75;1.10) per ten-
fold increase in allergen level], although there was a
significant association between sensitization to house
dust mites and log10-transformed HDM-allergen levels
[OR 1.54, (1.04;2.29) per tenfold increase in allergen
level].The association of wheeze with dampness in this
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subsample with dust measurements was slightly weaker
[OR 1.44 (0.94;2.21)] than in the full analysis with all
centres, although this difference between the dust-cen-
tres and other centres was not statistically significant.
Association of dampness with other health-related
outcomes
As there was no substantial confounding we report here
crude odds ratios, which retain the maximum number
of children in the analysis. Dampness was not associ-
ated with bronchial hyperresponsiveness, but was sig-
nificantly associated with rhinitis symptoms and even
more strongly with reported coughed up phlegm
(Table 3).
Due to the reduced number of centres contributing
data on cough and phlegm (18 centres, see Table 1), we
report for comparison here the association of dampness
with recent wheeze in these centres: the OR was 1.71
(1.47;1.99) in the children who had valid data for
‘Coughed up phlegm without a cold’ and 1.91
(1.51;2.41) in children with valid data for ‘Coughed up
phlegm frequently’. Thus, the association of dampness
with respiratory symptoms in general was stronger in
these centres.
The association of dampness with rhinitis symptoms
was stronger for non-affluent countries (Table 3), par-
ticularly with rhinoconjunctivitis [OR 2.17 (1.91;2.48)
in non-affluent countries and 1.37 (1.23;1.51) in
affluent countries]. The association with rhinoconjunc-
tivitis was stronger in children without reported
parental allergic disease [OR 1.73 (1.49;2.00) vs. 1.40
(1.22;1.60)] or without positive skin prick results, espe-
cially among those not sensitized to pollen [1.91
(1.64;2.22) vs. 1.11 (0.83;1.49)]. There was no effect
modification by sensitization to house dust mite (data
not shown).
Although there was a significant positive association
with reported eczema, there was no relation with exam-
ined eczema. This was not related to the selection of
Table 2. Association of dampness* with wheeze and effect modification: adjusted (for parental allergies) OR with 95%-CI unless otherwise indi-
cated
OR (95%-CI) N (children) N (centres)
P for difference
btw strata
All children
Crude OR 1.58 (1.40–1.79) 46 051 28
Adjusted OR 1.54 (1.39–1.72) 45 761 27
Crude in reduced adjustment data set 1.62 (1.44–1.82) 45 761 27
Children in the following strata
Affluent centres 1.39 (1.24–1.56) 28 592 18
Non-affluent centres 1.80 (1.57–2.06) 17 169 9 0.005
Atopics 1.69 (1.42–2.02) 6633 25
Non-atopics 1.54 (1.33–1.77) 19 786 26 0.403
HDM sensitized 1.68 (1.35–2.08) 3356 21
Not HDM sensitized 1.47 (1.28–1.68) 22 974 26 0.303
Parental allergies† 1.51 (1.31–1.74) 15 956 27
No parental allergies† 1.63 (1.41–1.89) 29 805 27 0.452
Parental asthma† 1.48 (1.13–1.93) 4205 25
No parental asthma† 1.63 (1.46–1.82) 40 884 27 0.508
Feather bedding 2.17 (1.56–3.02) 4034 17
No feather bedding 1.57 (1.37–1.80) 23 323 24 0.077
Feather pillow 1.82 (1.38–2.40) 5296 20
No feather pillow 1.58 (1.37–1.82) 22 652 24 0.365
Carpet 1.41 (1.18–1.68) 11 141 17
No carpet 1.62 (1.45–1.81) 31 274 23 0.187
Only double glazing windows 1.63 (1.30–2.05) 10 667 18
Also other types of windows 1.72 (1.50–1.97) 27 077 21 0.694
Air conditioning 1.63 (1.29–2.06) 10 312 18
No air conditioning 1.65 (1.46–1.87) 21 784 19 0.908
Environmental Tobacco Smoke (ETS) 1.49 (1.31–1.69) 20 552 24
No ETS 1.65 (1.37–1.98) 22 588 24 0.377
Bedroom sharing 1.57 (1.40–1.77) 28 404 24
No bedroom sharing 1.60 (1.35–1.90) 13 939 24 0.891
*Dampness defined as presence of damp spots and/or visible moulds in the child’s home.
†Crude odds ratio.
HDM, House dust mite (Dermatophagoides pteronyssinus or D. farinae).
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children with a skin exam, because the OR for reported
eczema when limited to those that had a skin examina-
tion [1.50 (1.26;1.78)] was almost identical to the esti-
mate based on the larger sample of children with data
for reported eczema.
Although there was no association with overall sensi-
tization, dampness was positively associated with sensi-
tization to house dust mite, but only in affluent centres
(Table 3). When children, whose parents reported hav-
ing made changes in bedding and carpets due to aller-
gies or asthma were omitted, the results did not change
(data not shown).
Discussion
Our results confirm that dampness is a potentially mod-
ifiable risk factor for wheeze world-wide. In particular,
our study that used the same methodology in all cen-
tres showed that the effect is even stronger in non-
affluent than in affluent countries. There was an
equally strong association with rhinitis symptoms and
an even stronger one for cough with phlegm, whereas
there was no association with bronchial hyperreactivity
and only a weak association with house dust mite sen-
sitization. Concentrations of house dust mite allergens
were higher in damp homes and were associated with
HDM-sensitization, but this did not account for the
observed association between dampness and wheeze,
which was found among both atopic and non-atopic
children. Our results stress the importance of non-ato-
pic processes, which is of considerable importance
given that only relatively small fractions of asthma,
rhinitis and eczema symptoms are attributable to atopy
in non-affluent centres and even in affluent countries
non-atopic symptoms are frequent [18, 20, 33]. Our
estimate of the odds ratio linking current dampness
with recent wheeze (1.6) is very similar to that cited in
reviews by Antova (2008) [34] [1.43 (1.36 to 1.49)] and
Fisk (2007) [35] [1.53 (1.39–1.68)]. The fact that our
result comes from a multi-centre study and is not sub-
ject to publication bias strengthens the evidence from
previous meta-analyses based mainly on literature
reviews [1, 34, 35].
Our odds ratio estimates for cough with phlegm (1.9)
are higher than those reported for children in Fisk
(2007) [35] and Antova (2008) [34] for cough (OR from
1.3 to 1.5). However, these meta-analyses included dif-
ferent definitions of cough and may therefore not be
directly comparable with ours. Our estimates for rhinitis
with and without conjunctivitis (1.3 to 1.6) are compa-
rable to these two reports covering upper respiratory
symptoms with odds ratios in the range from 1.3 to 1.7
[1, 34, 35]. Our OR for reported eczema of 1.5 is very
similar to that from a previous British study in school-
children that reported an OR of 1.4 [36].
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We did not find an association of dampness with
bronchial hyperresponsiveness, in contrast to other
studies in adults and among asthmatic children [37, 38]
as well as children from a Swedish population. How-
ever, no relationship was found between reported
dampness and exercise-induced bronchospasm among
Scottish children [39].
A special strength of the ISAAC collaborative frame-
work is the diversity of study centres. Most previous
studies of dampness and health have been carried out in
industrialized Western countries, and only a small num-
ber of previous studies in non-affluent countries such as
Kenya, Nigeria and Sri Lanka [2, 3, 40] have suggested
that dampness might be a risk factor world-wide.
Despite the consistent association of dampness with
symptoms of wheeze, rhinoconjunctivitis and eczema
the underlying mechanisms remain more speculative.
House dust mite exposure has been proposed as a medi-
ating factor [9, 41] relating to the fact that house dust
mites thrive well in humid environments (e.g. [42]) and
higher levels of the house dust mite allergen Der p1
were found in mattresses in bedrooms with higher mea-
sured humidity [43–45].
In our study, as in others [43] mite allergen levels
were indeed higher in mattress dust samples from
homes where the parents reported dampness. Further-
more, sensitization to house dust mite was also posi-
tively related to dampness and to HDM-allergen levels
in the smaller subsample. However, in this subsample
wheeze was not related to allergen levels and similar
results have been found in several cohort studies pub-
lished in the last decade [46, 47]. Also a study in Swe-
den, where mite levels are low, reported that there was
no relation between HDM-sensitization and either
current asthma or damp buildings [8].
In our study, the effect of dampness was very similar
in subjects with and without house dust mite sensitiza-
tion, which suggests that house dust mite allergy is not
the only or even the main pathway underlying the
observed association between dampness and wheeze.
However, it has recently been suggested that the effect
of house dust mite (allergens) may not always be IgE-
mediated, but could also involve airway remodelling in
asthmatics through other mechanisms [48].
Nevertheless, the dampness effect is observed world-
wide in very different climatic conditions including
areas where house dust mites do not occur frequently
(e.g. [49, 50]) suggesting that mite exposure can, at
best, explain only a part of the associations between
symptoms and dampness in homes [16].
Our study is unusual in reporting results stratified by
sensitization. Stratum-specific effects for atopic and
non-atopic individuals are reported in few studies with
partly contradictory results. A case-control study of
English primary schoolchildren suggested that the effect
of surface wall moisture on parent-reported wheeze was
stronger in atopics though the interaction term was not
statistically significant [51]. A case-control study of
newly diagnosed childhood asthma in Finland showed a
significantly stronger effect in atopic individuals for
visible mould, but no significant difference for moisture
damage [52]. Similarly, in children 7–8 years of age,
R€onmark et al. (1999) [53] found no significant differ-
ence in the association of dampness at home with ato-
pic and non-atopic asthma respectively. In our study,
the effect of dampness, including also visible moulds,
on wheeze was essentially the same in atopic and non-
atopic individuals.
The ISAAC data has previously shown [18, 20, 33]
that a substantial proportion of wheezing, rhinitis and
Table 3. Association of dampness* with respiratory and allergic outcomes: crude OR with 95%-CI
All centres Affluent Non-affluent
OR (95%-CI) N
N
(centres) OR (95%-CI) N
N
(centres) OR (95%-CI) N
N
(centres)
HDM-sensitization 1.16 (1.03–1.32) 26 560 25 1.25 (1.06–1.48) 17 367 15 1.01 (0.84–1.23) 9193 10
Positive skin prick test 0.99 (0.91–1.08) 26 967 27 0.99 (0.89–1.10) 17 774 17 0.99 (0.85–1.16) 9193 10
Bronchial hyperresponsiveness 0.90 (0.69–1.17) 5713 21 0.85 (0.61–1.18) 4582 15 0.95 (0.58–1.58) 1131 6
Rhinitis 1.51 (1.37–1.66) 45 774 28 1.38 (1.24–1.55) 28 466 18 1.71 (1.48–1.98) 17 308 10
Rhinoconjunctivitis 1.61 (1.42–1.83) 45 651 28 1.37 (1.23–1.51) 28 378 18 2.17 (1.91–2.48) 17 273 10
Rhinitis without conjunctivitis 1.27 (1.16–1.39) 45 378 27 1.30 (1.12–1.51) 28 102 17 1.25 (1.11–1.41) 17 276 10
Coughed up phlegm without a
cold
1.9 (1.59–2.26) 24 573 18 1.97 (1.52–2.56) 16 121 12 1.98 (1.63–2.40) 8452 6
Coughed up phlegm frequently 2.71 (2.15–3.41) 14 972 15 2.91 (1.89–4.49) 9524 9 2.64 (1.99–3.49) 5448 6
Flexural eczema symptoms past
year
1.52 (1.34–1.73) 45 856 28 1.34 (1.18–1.51) 28 544 18 1.96 (1.62–2.37) 17 312 10
Flexural eczema on skin
examination
0.95 (0.78–1.16) 25 966 23 0.92 (0.74–1.14) 18 879 16 1.10 (0.70–1.72) 7087 7
N, Number of children; HDM, House dust mite (Dermatophagoides pteronyssinus or D. farinae).
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eczema symptoms among children, particularly in less
affluent countries, is unlikely to have an atopic basis,
so the significantly stronger association between damp-
ness and wheeze in centres from less affluent countries
provides further argument for the link being through
non-atopic mechanisms such as non-allergic inflamma-
tory processes.
One limitation of our study is that the only mould
species we have information on sensitization for is
Alternaria alternata. Only a limited number of children
was sensitized to that mould species (1.5%) an even less
were sensitized exclusively to Alternaria (0.7%) with
most being also sensitized to house dust mite. In the
one centre that tested for sensitization to Cladosporium,
a similar pattern emerged (1% and 0.8% respectively).
Therefore, we could not perform a meaningful analysis
on this data. However, the low prevalence of Alternaria
and Cladosporium sensitization precludes a significant
role in the observed association of disease with damp-
ness. Although we cannot make any statements regard-
ing other mould species, they seem unlikely to be the
relevant mechanism, given that overall atopy is not
associated with dampness.
An explanation of a notable non-allergic effect could
relate to inflammatory reactions to cell wall compo-
nents such as 1,3-b-D-glucan [13–15] or volatile
organic compounds emanating from degrading building
materials or microbial activity [11, 12]. A recent study
in a population-based sample including children and
adults has found a relation between MVOCs such as 1-
octen-3-ol with rhinitis and conjunctivitis, though not
with asthma [54]. Furthermore, mycotoxins have been
shown to hinder macrophage functioning in vitro [55]
and animal models have shown inflammatory, non-
allergic respiratory effects with toxic fungal metabolites
[56] and a 1,3-b-D-glucan [57]. On the other hand, one
study in infants found that 1,3-b-D-glucan was nega-
tively associated with asthma in a longitudinal investi-
gation [58] which however could not be confirmed at
age three of the children [59].
One limitation to our study is that we report cross-
sectional associations and have no data on wheeze inci-
dence. However, the positive association was also found
when investigating early exposure retrospectively.
Potential over-reporting due to differential parental
recall may have exaggerated this association, although
the results were similar for current exposure.
In general, recall bias may have influenced the
results as parents of wheezy children may be more
likely to notice or report dampness due to perceived
health effects. Some previous studies have actually
found that the associations were stronger when damp-
ness was assessed by trained personnel or objective
measurements [39, 49, 60, 61] probably because this
personnel is trained to find moulds also in hidden loca-
tions. However, one study which compared parental
report with trained personnel reports actually found
that parents reported more damp spots, but there was
no over-reporting of parents of cases relative to parents
of controls [9]. While reporting bias is plausible and
reported in the literature from some affluent countries,
we found that the association was observed consistently
in diverse countries, even where preconceptions regard-
ing health effects are unlikely to occur.
We found no association of dampness with the objec-
tive measures of bronchial hyperresponsiveness and
skin examination, while the wheezing and eczema
symptoms showed a clear association. A third objective
measurement (house dust mite sensitization) did show
the expected association with dampness and with aller-
gen exposure.
However, BHR is not perfectly correlated with wheeze,
either at the individual level or the level of whole popu-
lations [19]. This may be, in part, because BHR is a mea-
sure at one point in time (point prevalence) and thus
fails to capture those with asymptomatic wheeze at the
time of the test but who have contributed to the 12-
month period prevalence of wheeze, therefore resulting
in a lower power. Similar considerations apply to the
relationship between examined eczema and reported
eczema. In addition, for BHR, the power of our study
was reduced because bronchial challenges were per-
formed in stratified subsamples in many centres.
Another limitation is that we are not able to distin-
guish whether the association with present exposure is
mainly due to inducing the development of the disease
or to triggering asthma symptoms in the past
12 months. However, the fact that the association holds
also true for children for which exposure was reported
only for the first year of life, that is, before the survey,
suggests that the effect is related to the onset of asthma
rather than triggering of asthma attacks.
In conclusion, our study confirms an adverse effect
of damp housing conditions on respiratory symptoms
based on results from centres world-wide. Exposure to
dampness, both at present and earlier in life was associ-
ated with wheeze occurrence as well as wheeze severity,
mainly, we suggest, through non-atopic mechanisms.
Further research is needed to investigate these non-
allergic pathways, the lesser contributing role of house
dust mite allergens, and the timing of the relevant envi-
ronmental exposures.
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